Organic Active Ingredients TRIZ Cases

Kidney-selective conjugates deliver protective compounds to renal tissue, preventing nephrotoxic damage from chemotherapy agents.

Carrageenan acts as a disintegrant in coated pellets, resolving the contradiction between chemical stability and rapid release speed.

Formula I compounds target mutant p53 isoforms to treat cancer and atherosclerosis without suppressing beneficial wild-type protein functions.

Modified DNA aptamer PNDA-3 blocks periostin-integrin interactions, resolving toxicity trade-offs in breast cancer treatment.

Dissolves oxazole compound in polar solvent to stabilize formulation and enable efficient skin absorption.

Hydrolyzed collagen peptides accelerate wound healing by supplying proline and hydroxyproline to reduce scarring and infection risk.

DUSP1 inhibitors selectively target myeloproliferative neoplasm cells, overcoming JAK2 inhibitor resistance and toxicity.

Tailoring voxelotor doses to 500-1000 mg daily prevents drug accumulation and adverse events in severe hepatic impairment.

A 1,2-HOPO chelating agent combined with sodium oleate enhances radionuclide excretion.

Choroid plexus secreted proteins accelerate wound healing while inhibiting scar tissue formation to preserve functional and cosmetic quality.

Deuterium-substituted gamma-carbolines inhibit serotonin reuptake and modulate dopamine signaling pathways.

Benzodioxane derivatives block leukotriene A4 hydrolase to reduce inflammatory responses in asthma and cardiovascular diseases.

Antibody-drug conjugates target PTCRA on tumor cells to deliver cytotoxic payloads, addressing the lack of targeted therapies for chemo-refractory T-ALL.

Rehydrated freeze-dried platelet derivatives restore hemostatic function through targeted thrombin generation.

3' end caps protect RNA interference agents from serum degradation, extending biological half-life while maintaining gene silencing activity.

Deuterated phenylamino pyrimidine compounds enhance oral bioavailability through localized isotopic substitution.

Specific pharmaceutical compounds inhibit TRPA1 channel activity, resolving inadequate ion channel modulation in current chemical warfare injury treatments.

Reducing cefdinir particle size to 10 µm via wet granulation overcomes low water solubility, boosting dissolution rate and bioavailability.

Developing fused triterpene compounds addresses the lack of effective RORγ modulators and IL-17 inhibitors for treating autoimmune disorders.

A liposome-based pharmaceutical composition delivers therapeutic agents via articular injection for joint pain management.

Prebiotic materials protect probiotics during transit, enabling effective colonization and restoring intestinal health.

Formula I pyrimidine compounds modulate delta opioid receptors to deliver targeted analgesic benefits.

High-dose capsaicin patches prune abnormal nerve fibers and stimulate regeneration, resolving chemotherapy-induced peripheral neuropathy pain.

Solvent classification controls amide form production below 5% weight to maintain antifungal activity despite stereoisomer generation.

A bioabsorbable scaffold uses a polymer coating to hold novolimus while limiting chemical bonding.

Sonication creates 100-500 kDa crosslinked hyaluronan that binds Hyal-2 receptors, suppressing tumor growth while avoiding high molecular weight promotion.

Amphotericin B culture supplement overcomes low virus yield restrictions in certified Vero cells by boosting replication efficiency.

Aryl pyridine compounds modulate protein kinase activity to treat diseases where existing methods fail across diverse conditions.

Continuous dialysis removes mineral impurities from freshwater fish scales, avoiding costly EDTA treatments that degrade collagen yield.

Measuring Hsp90 protein levels predicts c-Met inhibitor efficacy, overcoming resistance development in cancer therapy.

Blocking antibodies intercept IgE-FcεRI binding during desensitization, preventing severe reactions while maintaining treatment effectiveness.

An ethanol-free glycerol solution maintains thyroid hormone T4 absorption levels independent of gastric pH alterations.

Sublingual alprazolam tablets bypass liver metabolism to treat insomnia, avoiding benzodiazepine dependence and hangover effects.

Amphiphilic fatty acid compounds cross the blood-brain barrier to destroy glioblastoma stem cells while sparing normal brain tissue.

Compounds activate hCAR and Nrf2 to induce CYP2B6 expression, resolving cardiotoxicity from doxorubicin while boosting cyclophosphamide efficacy.

Alcohol extract of Ajuga taiwanensis suppresses cofilin-1 expression in human dermal fibroblasts.

Identifying VentX as a key regulator enables feedback control of macrophage differentiation, addressing complex inflammatory disease mechanisms.

Removing the disulfide bridge from gliotoxin enables blood-brain barrier penetration and reduces toxicity for treating opioid abuse.

Microbial conversion of heme yields meso-biliverdin IXα, expanding therapeutic options while improving production safety.

ZN-c3 WEE1 inhibitor abrogates the G2-M checkpoint to force DNA-damaged cancer cells into premature mitosis.

Substituted 2-(benzyloxy)pyrimidine compounds inhibit PD-1/PD-L1 activation to treat cancer.

Hydroxyprogesterone caproate modulates glucocorticoid receptors to reduce cytokine levels, addressing insufficient efficacy of conventional therapies.

Segmenting patients by proinflammatory and metabolic endophenotypes resolves the trade-off between treatment effectiveness and diagnostic complexity.

A portable laser system combines cutting optics with a modulation device to divert mobile tracking devices.

A pediatric nutritional composition combines polar lipids, prebiotics, and lactoferrin to support cognitive development.